4/A//SEC Filing
Kim Lorence H. 4/A
Accession 0001127602-20-018892
CIK 0001682852other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 6:33 PM ET
Size
5.7 KB
Accession
0001127602-20-018892
Insider Transaction Report
Form 4/AAmended
Moderna, Inc.MRNA
Kim Lorence H.
Chief Financial Officer
Transactions
- Sale
Common Stock
2020-05-15$63.80/sh−2,600$165,880→ 1,219,910 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on September 18, 2019.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.27 to $64.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001643746
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 6:33 PM ET
- Size
- 5.7 KB